$LNTH 3 SEC Filings

Filed On	Filing
18 Aug 2025	Form 3: Dinkelborg Ludger, See Remarks Holds 0 shares of Common Stock
18 Aug 2025	Form 3: Patel Rajiv A, Member of a Group Owning 10% and 7 others Holds 6,883,227 shares of Common Stock
18 Aug 2025	Form 3: Farallon Partners L L C/CA, 10% owner and 9 others Holds 6,883,227 shares of Common Stock
07 Feb 2025	Form 3: Morrow Phuong Khanh, Director Holds 0 shares of Common Stock
09 Sep 2024	Form 3: Eastland Julia Marie, Director Holds 0 shares of Common Stock
12 Aug 2024	Form 3: Brown Kimberly, Chief Accounting Officer Holds 0 shares of Common Stock
06 Jun 2024	Form 3: Humphrey Jeffrey, Chief Medical Officer Holds 0 shares of Common Stock
04 Apr 2024	Form 3: Morgan Amanda Michelle, Chief Commercial Officer Holds 25,411 shares of Common Stock
01 Feb 2024	Form 3: Lantheus Alpha Therapy, Llc, 10% owner and 1 other · Perspective Therapeutics, Inc. Holds 56,342,355 shares of Common Stock
10 Jan 2023	Form 3: Provost Jean-Claude, Chief Medical Officer Holds 4,464 shares of Common Stock
03 Mar 2022	Form 3: Baylor-Henry Minnie, Director Holds 0 shares of Common Stock
17 Dec 2021	Form 3: Yao Ying Vivian, Chief Human Resources Officer Holds 0 shares of Common Stock
02 Aug 2021	Form 3: Sabens Andrea, Chief Accounting Officer Holds 68,554 shares of Common Stock
10 May 2021	Form 3: Montagut Etienne, See Remarks Holds 95,154 shares of Common Stock
10 May 2021	Form 3: Niedzwiecki Daniel, See Remarks Holds 48,210 shares of Common Stock
10 May 2021	Form 3: Walker Carol, Senior Vice President, Quality Holds 76,203 shares of Common Stock
23 Jun 2020	Form 3: Ber Gerard, Director Holds 0 shares of Common Stock
23 Jun 2020	Form 3: Maeusli Heinz Christoph, Director Holds 0 shares of Common Stock
28 Jan 2020	Form 3: Blanchfield Paul, Chief Commercial Officer Holds 0 shares of Common Stock
13 Jan 2020	Form 3: Molnar Istvan, Chief Medical Officer Holds 0 shares of Common Stock

Comments